Difference between revisions of "HIV-1 aspartyl protease (FXIIIa)"
m |
|||
Line 2: | Line 2: | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
|- | |- | ||
− | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:HIV-1 aspartyl protease.png|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
− | | | + | | HIV-1 aspartyl protease |
|- | |- | ||
| Synonyms | | Synonyms |
Revision as of 15:18, 17 August 2007
Template:Infobox header| HIV-1 aspartyl protease (FXIIIa) | |
---|---|
HIV-1 aspartyl protease (FXIIIa) | |
Substrate peptide name | HIV-1 aspartyl protease |
Synonyms | - |
Determination type | In vitro |
Source | HIV |
Subcellular localization | HIV |
Swissprot ID | P04585 |
Reactive glutamines | Not determined yet |
Reactive lysines | Not determined yet |
Substrate sequence | |
Structure | 1A30 |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:1358064 |
Notes | |
Template:Infobox header | |